AI & LongevityStudy of ~50,000 past trials
A Stanford 'company' of 37,000 AI programs studied 50,000 drug trials
A virtual biotech with no human staff combed past trials for clues to which drugs succeed, then proposed a lung cancer drug idea a real drugmaker later pursued on its own.
JZJames Zou4 sources · 6 min
